As an Operating Partner for HealthEdge, Bob currently serves as Chief Executive Officer and Member of the Board of Directors of The Columbus Organization. Mr. Cunard also supports the evaluation of investment opportunities for HealthEdge Fund III.
Bob brings nearly three decades of experience in US pharmaceuticals from the perspectives of wholesaler, retailer, and manufacturer. Before joining HealthEdge, he was most recently CEO of Aurobindo Pharma USA, Inc., the largest subsidiary of Aurobindo Pharma Limited, an API and finished dosage form generic manufacturer headquartered in Hyderabad India, with annual revenue in excess of $2 billion. He joined Aurobindo in 2011 and lead five years of significant growth, generating 33% compound annual growth in the US business, contributing significantly to the 15x increase in corporate market capitalization to $6 billion.
Previously, Bob held numerous executive positions in Sales and Marketing with some of the generic pharmaceutical industry’s most notable companies, including Mylan Laboratories and Teva Pharmaceuticals. He began his career with Value Drug Company, a wholesale cooperative for independent retail pharmacy before joining Rite Aid Corporation, one of the nation’s largest pharmacy chains.
Bob holds a BA from the University of Pittsburgh in Business Economics. He lives with his wife and two children in New Hope, Pennsylvania.